These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 21763331)
1. Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats. Shen EY; Ali SF; Meyer JS Neuropharmacology; 2011 Dec; 61(8):1183-92. PubMed ID: 21763331 [TBL] [Abstract][Full Text] [Related]
2. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram. Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680 [TBL] [Abstract][Full Text] [Related]
3. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats. Piper BJ; Ali SF; Daniels LG; Meyer JS Synapse; 2010 Jun; 64(6):421-31. PubMed ID: 20169574 [TBL] [Abstract][Full Text] [Related]
4. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). McNamara R; Kerans A; O'Neill B; Harkin A Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283 [TBL] [Abstract][Full Text] [Related]
5. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist. Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566 [TBL] [Abstract][Full Text] [Related]
7. Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat. Cox BM; Shah MM; Cichon T; Tancer ME; Galloway MP; Thomas DM; Perrine SA Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():229-35. PubMed ID: 24121061 [TBL] [Abstract][Full Text] [Related]
8. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine. Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842 [TBL] [Abstract][Full Text] [Related]
10. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443 [TBL] [Abstract][Full Text] [Related]
11. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472 [TBL] [Abstract][Full Text] [Related]
12. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain. Izco M; Orio L; O'Shea E; Colado MI Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928 [TBL] [Abstract][Full Text] [Related]
13. Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption. Llorente-Berzal A; Puighermanal E; Burokas A; Ozaita A; Maldonado R; Marco EM; Viveros MP PLoS One; 2013; 8(11):e78386. PubMed ID: 24223797 [TBL] [Abstract][Full Text] [Related]
14. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. Biezonski DK; Meyer JS J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520 [TBL] [Abstract][Full Text] [Related]
15. Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats. Young JM; McGregor IS; Mallet PE Neuropsychopharmacology; 2005 Aug; 30(8):1475-82. PubMed ID: 16178074 [TBL] [Abstract][Full Text] [Related]
16. Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats. Lopez-Rodriguez AB; Llorente-Berzal A; Garcia-Segura LM; Viveros MP Br J Pharmacol; 2014 Mar; 171(6):1435-47. PubMed ID: 24236988 [TBL] [Abstract][Full Text] [Related]
17. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug. Camarasa J; Pubill D; Escubedo E Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759 [TBL] [Abstract][Full Text] [Related]
18. Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats. Lizarraga LE; Phan AV; Cholanians AB; Herndon JM; Lau SS; Monks TJ Toxicol Sci; 2014 Jun; 139(2):421-31. PubMed ID: 24595820 [TBL] [Abstract][Full Text] [Related]
19. On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats. Goñi-Allo B; Puerta E; Mathúna BO; Hervias I; Lasheras B; de la Torre R; Aguirre N Neuropharmacology; 2008 Apr; 54(5):885-900. PubMed ID: 18329670 [TBL] [Abstract][Full Text] [Related]
20. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats. Stanley N; Salem A; Irvine RJ Neuroscience; 2007 Apr; 146(1):321-9. PubMed ID: 17306465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]